Caroline von Spee-Mayer

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Caroline von Spee-Mayer, Elise Siegert, Dimas Abdirama et al. · Annals of the Rheumatic Diseases · 2015 · 325 citations

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients

Omri Snir, Mona Widhe, Monika Hermansson et al. · Arthritis & Rheumatism · 2009 · 202 citations · Full text

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles

Omri Snir, Mona Widhe, Caroline von Spee-Mayer et al. · Annals of the Rheumatic Diseases · 2008 · 191 citations

Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial

Jens Y. Humrich, Caroline von Spee-Mayer, Elise Siegert et al. · The Lancet Rheumatology · 2019 · 74 citations

Rheumatology, Autoimmune Disease, Systemic Lupus Erythematosus Treatment +10

CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice

Olivia Weigert, Caroline von Spee-Mayer, Reinmar Undeutsch et al. · Arthritis Research & Therapy · 2013 · 56 citations · Full text